U.S. markets open in 7 hours 26 minutes
  • S&P Futures

    4,171.00
    +13.25 (+0.32%)
     
  • Dow Futures

    34,367.00
    +111.00 (+0.32%)
     
  • Nasdaq Futures

    13,376.50
    +73.00 (+0.55%)
     
  • Russell 2000 Futures

    2,235.20
    +9.70 (+0.44%)
     
  • Crude Oil

    66.47
    +0.20 (+0.30%)
     
  • Gold

    1,870.60
    +3.00 (+0.16%)
     
  • Silver

    28.65
    +0.38 (+1.33%)
     
  • EUR/USD

    1.2173
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    1.6400
    0.0000 (0.00%)
     
  • Vix

    19.72
    +0.91 (+4.84%)
     
  • GBP/USD

    1.4173
    +0.0036 (+0.25%)
     
  • USD/JPY

    109.1020
    -0.0980 (-0.09%)
     
  • BTC-USD

    45,388.70
    +623.30 (+1.39%)
     
  • CMC Crypto 200

    1,263.22
    +65.30 (+5.45%)
     
  • FTSE 100

    7,032.85
    -10.76 (-0.15%)
     
  • Nikkei 225

    28,449.75
    +624.92 (+2.25%)
     

BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

FOOTHILL RANCH, Calif., March 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)
BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 353-6461. For international participants outside the U.S./Canada, the dial-in number is (334) 323-0501. For all callers, refer to the Conference ID 7623727. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-fourth-quarter-and-full-year-2020-results-on-march-25-2021-301249159.html

SOURCE BIOLASE, Inc.